Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session Marlborough, ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...

Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Larry Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children's Hospital, presented a session at ...

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...

Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology. The officers and board members are all ...

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...